Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-13

FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Original Application (Shandong Luye Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved RYKINDO EXTENDED-RELEASE MICROSPHERES, an oral extended-release formulation of risperidone from Shandong Luye Pharmaceutical, under its Original Ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RYKINDO EXTENDED-RELEASE MICROSPHERES (risperidone)

Snippet

ORIG AP for RYKINDO EXTENDED-RELEASE MICROSPHERES (RISPERIDONE)